World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders

References

• Agras WS, Dorian B, Kirkley BG, Arnow B, Bachman J. 1987. Imipramine in the Treatment of Bulimia: A Double-blind Controlled Study. Int J Eat Dis 6:29–38.
   Web of Science ®Google Scholar
• Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, . 1992. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry 149:82–87.
   PubMed Web of Science ®Google Scholar
• Agras WS, Rossiter EM, Arnow B, Telch CF, Raeburn SD, Bruce B, Koran LM. 1994. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa. J Clin Psychiatry 55:179–183.
   PubMed Web of Science ®Google Scholar
• Alger SA, Schwalberg MD, Bigaoueite JM, Michalek AV, Howard LJ. 1991. Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr 53:865–871.
   PubMed Web of Science ®Google Scholar
• APA. 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV). Washington, DC: American Psychiatric Press.
   Google Scholar
• Appolinario JC, Fontenelle FL, Papelbaum M, Bueno JR, Coutinho W. 2002. Topiramate use in obese Patients with Binge Eating Disorder: An Open Study. Can J Psychiatry 47:271–273.
   PubMed Web of Science ®Google Scholar
• Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, . 2003. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 60:1109–1109.
   PubMed Web of Science ®Google Scholar
• Appolinario JC, Godoy-Matos A, Fontenelle LF, Carraro L, Cabral M, Vieira A, Coutinho W. 2002. An open-label trial of sibutramine in obese patients with binge-eating disorder. J Clin Psychiatry 63:28–30.
   PubMedGoogle Scholar
• Arnold LM, McElroy SL, Hudson JI, Welge JA, Bennett AJ, Keck PE. 2002. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 63:1028–1028.
   PubMed Web of Science ®Google Scholar
• Attia E, Haiman C, Walsh BT, Flater SR. 1998. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 155:548–551.
   PubMed Web of Science ®Google Scholar
• Bacaltchuk J, Hay P. 2003. Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database Syst Rev(4):CD003391.
   Google Scholar
• Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ; WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders. 2008. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision. World J Biol Psychiatry 9:248–248.
   PubMed Web of Science ®Google Scholar
• Barbarich NC, McConaha CW, Gaskill J, La Via M, Frank GK, Achenbach S, . 2004. An opentrial of olanzapine in Anorexia nervosa. J Clin Psychiatry 65:1480–1482.
   PubMed Web of Science ®Google Scholar
• Barlow J, Blouin J, Blouin A, Perez E. 1988. Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychiatry 33:129–133.
   PubMed Web of Science ®Google Scholar
• Bartra J, Valero AL, del Cavillo A, Devila I, JAuregui I, Monitoro J, Mullo J, Sastre J. 2006 Interactions of the H1 Antihistamines. J Investig Allergol Clin Immunol 16 Suppl 1:29–36.
   Google Scholar
• Bauer C, Fischer A, Keller U. 2006. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder. Diabetes Obes Metab 8:289–289.
   PubMed Web of Science ®Google Scholar
• Berkman ND, Lohr KN, Bulik CM. 2007. Outcomes of eating disorders: a systematic review of the literature. Int J Eat Disord. 40:293–309.
   PubMed Web of Science ®Google Scholar
• Berry EM, Mechoulam R. 2002. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacology & Therapeutics 95:185–190.
   PubMed Web of Science ®Google Scholar
• Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak PJ, Schildkraut JJ. 1985. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol 5:10–6.
   PubMed Web of Science ®Google Scholar
• Birmingham CL, Goldner EM, Bakan R. 1994. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord 15:251–255.
   PubMed Web of Science ®Google Scholar
• Birmingham CL, Gritzner S. 2006. How does zinc supplementation benefit anorexia nervosa? Eat Weight Disord 11:109–109.
   Google Scholar
• Bissada H, Tasca GA, Barber AM, Bradwejn J. 2008. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 165:1281–1281.
   PubMed Web of Science ®Google Scholar
• Boachie A, Goldfield GS, Spettigue W. 2003. Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports. Int J Eat Disord 33:98–103.
   PubMed Web of Science ®Google Scholar
• Bosanac P, Kurlender S, Norman T, Hallam K, Wesnes K, Manktelow T, Burrows G. 2007. An open-label study of quetiapine in anorexia nervosa. Hum Psychopharmacol 22:223–223.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Draisci A, Peirone A, Brunetta M. 1995a. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 1. Anorexia nervosa—restricted type. Neuropsychobiology;32:59–63.
   Google Scholar
• Brambilla F, Draisci A, Peirone A, Brunetta M. 1995b. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa—binge-eating/purging type. Neuropsychobiology 32:64–7.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Draisci A, Peirone A, Brunetta M. 1995c. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa. Neuropsychobiology 32:68–68.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, 2007. Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol 22:197–197.
   PubMed Web of Science ®Google Scholar
• Braun DL, Sunday SR, Fornari VM, Halmi KA. 1999. Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo-controlled study. Compr Psychiatry 40:442–8.
   PubMedGoogle Scholar
• Broft AI, Spanos A, Corwin RL, Mayer L, Steinglass J, Devlin MJ, . 2007. Baclofen for Binge Eating: an open-label trial. Int J Eat Disord 40:687–691.
   PubMed Web of Science ®Google Scholar
• Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL. 2006. Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry 63:305–305.
   PubMed Web of Science ®Google Scholar
• Claudino AM, Hay P, Lima MS, Bacaltchuk J, Schmidt U, Treasure J. 2006. Antidepressants for anorexia nervosa. Cochrane Database Syst Rev 25;(1):CD004365.
   Google Scholar
• Claudino AM, de Oliveira IR, Appolinario JC, Cordas TA, Duchesne M, Sichieri R, Bacaltchuk J. 2007. Double blind, randomized, placebo controlled trial plus cognitive behaviour therapy in binge eating disorder. J Clin Psychiatry 68:1324–1324.
   PubMed Web of Science ®Google Scholar
• Carruba MO, Cuzzolaro M, Riva L, Bosello O, Liberti S, Castra R, . 2001. Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial. International Clinical Psychopharmacology 16:27–32.
   PubMed Web of Science ®Google Scholar
• Casper RC, Schlemmer RF Jr, Javaid JI. 1987. A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res 20:249–260.
   PubMed Web of Science ®Google Scholar
• Cassano GB, Miniati M, Pini S, Rotondo A, Banti S, Borri CH, . 2003 Six-month open trial of haloperidol as an adjunctive treatment for Anorexia nervosa: a preliminary report. Int J Eat Disord 33:172–177.
   PubMed Web of Science ®Google Scholar
• Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. 2005. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 15;293:2873–83.
   Google Scholar
• Claudino AM, de Oliveira IR, Appolinario JC, Cordás TA, Duchesne M, Sichieri R, Bacaltchuk J. 2007. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J Clin Psychiatry 68:1324–1332.
   PubMed Web of Science ®Google Scholar
• Cordás TA, Tavares H, Calderoni DM, Stump GV, Ribeiro RB. 2006. Oxcarbazepine for self-mutilating bulimic patients. Int J Neuropsychopharm 9:789–771.
   Google Scholar
• Court A, Mulder C, Kerr M, Yuen HP, Boasman M, Goldstone S, Fleming J, Weigall S, Derham H, Huang C, McGorry P, Berger G. 2010. Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: a pilot study. J Psychiatr Res. 44:1027–34.
   PubMed Web of Science ®Google Scholar
• Crisp AH, Lacey JH, Crutchfield M. 1987. Clomipramine and “Drive” in people with anorexia nervosa: An in-patient study. Br J Psychiatry 150:355–358.
   PubMed Web of Science ®Google Scholar
• Coughlin JW, Edwards R, Buenaver L, Redgrave G, Guarda AS, Haythornthwaite J. 2008. Pain, catastrophizing, and depressive symptomatology in eating disorders. Clin J Pain. 24:406–414.
   Google Scholar
• De Bernardi C, Ferrarsi S, D'Innella P, Do F, Torre E. 2005. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29:339–339.
   Google Scholar
• De Zwaan M, Nutzinger DO, Schoenbeck G. 1992. Binge eating in overweight women. Compr Psychiatry 33:256–261.
   PubMed Web of Science ®Google Scholar
• Devlin MJ, Goldfein JA, Petkova E, Jiang H, Raizman PS, Wolk S, . 2005. Cognitive Behavioral Therapy and Fluoxetine as Adjuncts to Group Behavioral Therapy for Binge Eating Disorder. Obes Res 13:1077–1088.
   PubMedGoogle Scholar
• Devlin MJ, Goldfein JA, Petkova E, Liu L, Walsh BT. 2007. Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up. Obesity 15:1702–1709.
   PubMed Web of Science ®Google Scholar
• El-Giamal N, de Zwaan M, Bailer U, Lennkh C, Schüssler P, Strnad A, Kasper S. 2000. Reboxetine in the treatment of bulimia nervosa: a report of seven cases. Int Clin Psychopharmacol 15:351–256.
   PubMed Web of Science ®Google Scholar
• Fahy TA, Eisler I, Russel GFM. 1993. A placebo-controlled trial of d-Fenflurame in bulimia nervosa. Br J Psychiatry 162:597–603.
   PubMed Web of Science ®Google Scholar
• Fassino S, Leombruni P, Daga G, Brustolin A, Migliaretti G, Cavallo F, Rovera G. 2002. Efficacy of citalopram in anorexia nervosa: a pilot study. Eur Neuropsychopharmacol 12:453–459.
   PubMed Web of Science ®Google Scholar
• Faris PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, . 2000. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet 355:792–797.
   PubMed Web of Science ®Google Scholar
• Fassino S, Leombruni P, Daga G, Brustolin A, Migliaretti G, Cavallo F, . 2002. Efficacy of citalopram in anorexia nervosa: a pilot study. Eur Neuropsychopharmacol 12:453–459.
   PubMed Web of Science ®Google Scholar
• Fazeli PK, Lawson EA, Prabhakaran R, Miller KK, Donoho DA, Clemmons DR, . 2010. Effects of Recombinant Human Growth Hormone in Anorexia Nervosa: A Randomized, Placebo-Controlled Study. J Clin Endocrinol Metab. 95:4889–97.
   PubMed Web of Science ®Google Scholar
• Fichter MM, Leibl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR. 1991. Fluoxetine versus placebo: a double blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 24:1–7.
   PubMed Web of Science ®Google Scholar
• Fichter MM, Krüger R, Rief W, Holland R, Döhne J. 1996. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specefic psychopathology. J Clin Psychopharmacol 16:9–18.
   PubMed Web of Science ®Google Scholar
• Fisman S, Steele M, Short J, Byrne T, Lavallee C. 1996. Case study: anorexia nervosa and autistic disorder in an adolescent girl. J Am Acad Child Adolesc Psychiatry 35:937–937.
   PubMed Web of Science ®Google Scholar
• Fletcher BC, Kupshik GA, Uprichard S, Shah S, Nash AS. 2008. Eating disorders and concurrent psychopathology: a reconceptualisation of clinical need through Rasch analysis. Eur Eat Disord Rev 16:191–198.
   PubMed Web of Science ®Google Scholar
• Fontenelle LF, Vĺtor Mendlowicz M, de Menezes GB, Papelbaum M, Freitas SR, Godoy-Matos A, . 2003. Psychiatric comorbidity in a Brazilian sample of patients with binge eating disorder. Psychiatry Res 119:189–194.
   PubMed Web of Science ®Google Scholar
• Gadalla T, Piran N. 2007. Co-occurrence of eating disorders and alcohol use disorders in women: a meta analysis. Arch Womens Ment Health 10:133–140.
   PubMed Web of Science ®Google Scholar
• Glassman AH, Bigger JT, 2001. Antipsychotic drugs: prolonged QT-interval, torsade de pointes and sudden death. Am J Psychiatry 158:1774–1774.
   PubMed Web of Science ®Google Scholar
• Golay A, Laurent-Jaccard A, Habicht F, Gachoud JP, Chabloz M, Kammer A, . 2005. Effect of Orlistat in Obese Patients with Binge Eating Disorder. Obes Res 13:1701–1708.
   PubMedGoogle Scholar
• Goldbloom DS, Olmsted M, Davis R, Clewes J, Heinmaa M, Rockert W, Shaw B. 1997. A randomised controlled trial of fluoxetine and cognitive behavioural therapy for bulimia nervosa: short-term outcome. Behav Res Ther 35:803–811.
   PubMed Web of Science ®Google Scholar
• Goldberg SC, Halmi KA, Eckert ED, Casper RC, Davis JM. 1979. Cyproheptadine in anorexia nervosa. Br J Psychiatry 134:67–70.
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, and Rampey AH. 1995. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine bulimia nervosa reearch group. Br J Psychiatry 166:660–666.
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Wilson MG, Ascroft RC, Al-Banna M. 1999. Effectiveness of Fluoxetine Therapy in Bulimia Nervosa Regardless of Comorbid Depression. Int J Eat Disord 25:19–27.
   PubMed Web of Science ®Google Scholar
• Gotoh K, Fukagawa K, Fukagawa T, Noguchi H, Kakuma T, Sakata T, Yoshimatsu H. 2007. Hypothalamic neuronal histamine mediates the thyrotropin-releasing hormone-induced suppression of food intake. J Neurochem 103:1102–1102.
   Google Scholar
• Grilo CM, Masheb RM, Salant SL. 2005. Cognitive Behavioral Therapy Guided Self-Help and Orlistat for the Treatment of Binge Eating Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. Biol Psychiatry 57:1193–1201.
   PubMed Web of Science ®Google Scholar
• Grilo CM, Masheb RM, Wilson GT. 2005. Efficacy of Cognitive Behavioral Therapy and Fluoxetine for the Treatment of Binge Eating Disorder: A Randomized Double-Blind Placebo-Controlled Comparison. Biol Psychiatry 57:301–309.
   PubMed Web of Science ®Google Scholar
• Grilo CM, Masheb RM. 2007. Rapid response predicts binge eating and weight loss in binge eating disorder: Findings from a controlled trial of orlistat with guided self-help cognitive behavioral therapy. Behav Res Ther 45:2537–2537.
   Google Scholar
• Gross H, Ebert MH, Faden VB, Goldberg SC, Kaye WH, Caine ED, . 1983. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol 3:165–171.
   PubMed Web of Science ®Google Scholar
• Gross HA, Ebert MH, Faden VB, Goldberg SC, Nee LE, Kaye WH. 1981. A double-blind controlled trial of lithium carbonate primary anorexia nervosa. J Clin Psychopharmacol1:376–381.
   PubMed Web of Science ®Google Scholar
• Guerdjikova AI, Kotwal R, McElroy SL. 2005. Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery. Obes Surg 15:273–277.
   PubMed Web of Science ®Google Scholar
• Guerdjikova AI, McElroy SL, Kotwal R, Welge JA, Nelson E, Lake K, . 2008. High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. Hum Psychopharmacol 23:1–11.
   PubMed Web of Science ®Google Scholar
• Gwirtsman HE, Guze BH, Yager J, Gainsley B. 1990. Fluoxetine treatment of Anorexia Nervosa: an open clinical trial. J Clin Psychiatry 51:378–382.
   PubMed Web of Science ®Google Scholar
• Halmi KA, Eckert E, LaDu TJ, Cohen J. 1986. Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 43:177–181.
   PubMed Web of Science ®Google Scholar
• Halmi KA, Eckert E, Marchi P, Sampugnaro V, Apple R, Cohen J. 1991. Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry 48:712–718.
   PubMed Web of Science ®Google Scholar
• Hazen E, Fava M. 2005. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report. J Psychopharm 20:723–724.
   Google Scholar
• Hedges DW, Reimherr FW, Hoopes SP, Rosenthal NR, Kamin M, Karim R, Capece JA. 2003. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J Clin Psychiatry 64(12):1449–54.
   PubMed Web of Science ®Google Scholar
• Hill K, Bucuvalas J, McClain C, Kryscio R, Martini RT, Alfaro MP, Maloney M. 2000. Pilot study of growth hormone administration during the refeeding of malnourished anorexia nervosa patients. J Child Adolesc Psychopharmacol 10:3–3.
   PubMed Web of Science ®Google Scholar
• Holtkamp K, Konrad K, Kaiser N, Ploenes Y, Heussen N, Grzella I, Herpertz-Dahlmann B. 2005. A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. J Psychiatr Res 39:303–10.
   PubMed Web of Science ®Google Scholar
• Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, Capece JA, Karvois D. 2003 Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry 64:1335–41.
   PubMed Web of Science ®Google Scholar
• Horne RL, Ferguson JM, Pope HG, Hudson JI, Lineberry CG, Ascher J, Cato A. 1988. Treatment of Bulimia with bupropion: A Mulitcenter Controlled Trial. J Clin Psychiatry 49:262–262.
   PubMed Web of Science ®Google Scholar
• Hsu LKG, Clement L, Santhouse R, Ju ES 1991. Treatment of bulimia nervosa with lithium carbonate. A controlled study. J Nerv Ment Dis 179:351–351.
   PubMed Web of Science ®Google Scholar
• Hudson J, Pope H, Jonas J. 1984. Psychosis in Anorexia Nervosa und Bulima. Br J Psychiatry 145:420–423.
   PubMed Web of Science ®Google Scholar
• Hudson JI, McElroy SL, Raymond NC, Crow S, Keck PE Jr, Carter WP, . 1998. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 155:1756–1762.
   PubMed Web of Science ®Google Scholar
• Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. 2007. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 61:348–358.
   PubMed Web of Science ®Google Scholar
• Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM. 1986. Treatin bulimia with desipramine. A double-blind, placebo-controlled study. Arch Gen Psychiatry 43:182–186.
   PubMed Web of Science ®Google Scholar
• Huseman CA, Pearson PH, Leuschen MP, Madison J. 1990. Bulimia as a form of self-addiction treatment with Naltrexone hydrochloride (Trexan) a pilot study. Clinical Trials Journal 27:77–83.
   Google Scholar
• Jacobi C, Dahme B, Dittmann R. 2002. Cognitive-behavioural, fluoxetine and combined treatment for bulimia nervosa: short- and long-term results. Eur Eat Disorders 10:179–179.
   Web of Science ®Google Scholar
• Javaras KN, Pope HG, Lalonde JK, Roberts JL, Nillni YI, Laird NM, . 2008. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry 69:266–266.
   PubMed Web of Science ®Google Scholar
• Jensen VS, Mejlhede A. 2000. Anorexianervosa:treatment with olanzeapine. Br J Psych 177:87.
   PubMed Web of Science ®Google Scholar
• Jonas JM, Gold MS. 1986. Treatment of antidepressant-resistant bulimia with naltrexone. Int J Psychiatry in Medicine 16:306–309.
   Google Scholar
• Jonas JM, Gold MS. 1988. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Psychiatry Res ;24:195–199.
   PubMed Web of Science ®Google Scholar
• Jordan J, Joyce PR, Carter FA, Horn J, McIntosh VV, Luty SE, . 2008. Specific and nonspecific comorbidity in anorexia nervosa. Int J Eat Disord 41:47–56.
   PubMed Web of Science ®Google Scholar
• Kaplan AS, Garfinkel PE, Darby PL, Garner DM. 1983. Cabamazepine in the treatment of bulimia. Am J Psychiatry 140:1225–1226.
   PubMed Web of Science ®Google Scholar
• Katz RL, Keen CL, Litt IF, Hurley LS, Kellams-Harrison KM, Glader LJ. 1987. Zinc deficiency in anorexia nervosa. J Adolesc Health Care 8:400–406.
   PubMedGoogle Scholar
• Kaye W. 2008. Neurobiology of anorexia and bulimia nervosa. Physiology & Behavior 94:121–135.
   PubMed Web of Science ®Google Scholar
• Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C, . 2001. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry 49:644–652.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE. 1988. A trial of isacarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 8:391–391.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Goldbloom DS, Ralevski E, Davis C, D'Souza JD, Lofchy J. 1993. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. J Clin Psychopharmacol 13:415–415.
   PubMed Web of Science ®Google Scholar
• Keski-Rahkonen A, Hoek HW, Linna MS, Raevuori A, Sihvola E, Bulik CM, . 2008. Rissanen A, Kaprio J. Incidence and outcomes of bulimia nervosa: a nationwide population-based study. Psychol Med 8:1–9.
   Google Scholar
• Klump KL, Gobrogge KL. 2005. A Review and Primer of Molecular Genetic Studies of Anorexia Nervosa. Int J Eat Disord 37:43–S48.
   Google Scholar
• Kotler LA, Devlin MJ, Davies M, Walsh BT. 2003. An open trial with fluoxetine for adolescents with bulimia nervosa. J Child and Adolescent Psychopharmacology 13:329–335.
   PubMed Web of Science ®Google Scholar
• Konturek PC, Konturek JW, Cześnikiewicz-Guzik M, Brzozowski T, Sito E, Konturek SJ. 2005. Neuro-hormonal control of food intake: basic mechanisms and clinical implications. J Physiol Pharmacol.; 56 Suppl 6:5–25.
   Google Scholar
• Kuchar DL, Walker BD, Thorburn CW, 2002. Ventricular tachycardia following ingestion of a commonly-used antihistamine. MJA 176:429–429.
   Google Scholar
• La Via MC, Gray N, Kaye WH. 2000. Case reports of Olanzapine treatment of anorexia nervosa. Int J Eat Disord. 27:363–363.
   PubMed Web of Science ®Google Scholar
• Lacey JH, Crisp AH. 1980. Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 56 (Suppl 1):79–85.
   Google Scholar
• Laederach-Hofmann K, Graf C, Horber F, Lippuner K, Lederer S, Michel R, Schneider M. 1999. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. Int J Eat Disord 26:231–244.
   PubMed Web of Science ®Google Scholar
• Lam RW, Goldner EM, Solyom L, Remick RA. 1994. A controlled study of light therapy for bulimia nervosa. Am J Psychiatry 1515:744–750.
   Google Scholar
• Leitenberg H, Rosen JC, Wolf J, Vara LS, Detzer MJ, Srebenik D. 1994. Comparison of cognitive-behaviour therapy and desipramine in the treatment of builimia nervosa. Behav Res Ther 32:37–45.
   PubMed Web of Science ®Google Scholar
• Leggero C, Masi G, Brunori E, Calderoni S, Carissimo R, Maestro S, Muratori F. 2010. Low-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hyperactivity. J Child Adolesc Psychopharmacol. 2010;20:127–33.
   PubMed Web of Science ®Google Scholar
• Leombruni P, Amianto F, Delsedime N, Gramaglia C, Abbate-Daga G, Fassino S. 2006. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial. Adv Ther 23:481–481.
   PubMed Web of Science ®Google Scholar
• Leombruni P, Gastaldi F, Lavagnino L, Fassino S. 2008. Oxcarbazepine for the treatment of binge eating disorder: a case series. Adv Ther 25:718–724.
   PubMedGoogle Scholar
• Maahs D, de Serna DG, Kolotkin RL, Ralston S, Sandate J, Qualls C, Schade DS. 2006. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract 12:18–28.
   PubMedGoogle Scholar
• Maccarrone M, Gasperi V, Catani MV, Diep TA, Dainese E, Hansen HS, Avigliano L. 2010. The endocannabinoid system and its relevance for nutrition. Annu Rev Nutr. ;30:423–40.
   PubMed Web of Science ®Google Scholar
• Malina A, Gaskill J, McConaha C, Frank GK, LaVia M, Scholar L, . 2003. Olanzapine Treatment of Anorexia Nervosa: A Retrospective Study. Inc Int J Eat Disord 33:234–237.
   PubMed Web of Science ®Google Scholar
• Makino M, Tsuboi K, Dennerstein L. 2004. Prevalence of eating disorders: a comparison of Western and non-Western countries. MedGenMed 6:49.
   PubMedGoogle Scholar
• Mannucci E, Rotella F, Ricca V, Moretti S, Placidi GF, Rotella CM. 2005. Eating disorders in patients with type 1 diabetes: a meta-analysis. J Endocrinol Invest 285:417–419.
   Google Scholar
• Malhotra S, King KH, Welge JA, Brusman-Lovins L, McElroy SL. 2002. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. J Clin Psychiatry 63:802–806.
   PubMed Web of Science ®Google Scholar
• Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W. 1990. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychiatry 147:876–881.
   PubMed Web of Science ®Google Scholar
• Marrazzi MA, Bacon JP, Kinzie J, Luby ED. 1995. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 10:163–172.
   PubMed Web of Science ®Google Scholar
• McCallum RW, Grill BB, Lange R, Planky M, Glass EE, Greenfeld DG. 1985. Definition of a gastric emptying abnormality in patients with anorexia nervosa. Dig Dis Sci 30:713–722.
   PubMed Web of Science ®Google Scholar
• McCann UD, Agras WS. 1990. Successful treatment on nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry 147:1509–1513.
   PubMed Web of Science ®Google Scholar
• McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Hubbard VS, Yanovski JA. 2002. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res. 10:642–50.
   PubMedGoogle Scholar
• McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Frazer TE, Van Hubbard S, Yanovski JA. 2004. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab. 17:307–307.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Casuto LS, Nelson EB, Lake KA, Soutullo CA, Keck PE, Hudson JI. 2000. Placebo-Controlled Trial of Sertraline in the Treatment of Binge Eating Disorder. Am J Psychiatry 157:1004–1006.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Arnold LM, Shapira NA, Rosenthal NR, Karim MR, Kamin M, . 2003. Topiramate in the Treatment of Binge Eating Disorder Associated With Obesity: A Randomized, Placebo-Controlled Trial. Am J Psychiatry 160:255–261.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Shapira NA, Arnold LM, Keck PE, Rosenthal NR, Wu SC, . 2004. Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 65:1463–1469.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Kotwal R, Hudson JI, Nelson EB, Keck PE. 2004. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. J Clin Psychiatry 65:50–66.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Kotwal R, Guerdjikova AI, Welge JA, Nelson EB, Lake KA, . 2006. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry 67:1897–1906.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR. 2007a. Topiramate for the treatment of Binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 61:1039–1048.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Guerdjikova A, Kotwal R, Welge JA, Nelson EB, Lake KA, . 2004b. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. J Clin Psychiatry 68:390–398.
   Google Scholar
• Mehler-Wex C, Romanos M, Kirchheiner J, Schulze UM. 2008. Atypical antipsychotics in severe anorexia nervosa in children and adolescents—review and case reports. Eur Eat Disord Rev. 16(2):100–8.
   Google Scholar
• Milano W, Petrella C, Casella A, Capasso A, Carrino S, Milano L. 2005. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study. Adv Ther 22:25–25.
   PubMed Web of Science ®Google Scholar
• Milano W, Petrella C, Sabatino C, Capasso A. 2004. Treatment of bulimia nervosa with sertraline: a randomized controlled trial. Adv Ther 21:232–237.
   PubMed Web of Science ®Google Scholar
• Milano W, Siano C, Putrella C, Capasso A. 2005. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Adv Ther 223:278–283.
   Google Scholar
• Mitchell JE, Groat R. 1984. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 4:186–186.
   PubMed Web of Science ®Google Scholar
• Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. 1990. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 47:149–149.
   PubMed Web of Science ®Google Scholar
• Mitchell JE, Fletcher L, Hanson K, Mussell MP, Seim H, Al-Banna M, Wilson M, Crosby RD. 2001. The relative efficacy of fluoxetine and manual-based self-help therapy in the treatment of outpatients with bulimia nervosa. Journal of Clinical Psychopharmacology 21:293–304.
   Google Scholar
• Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P. 2005. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry 13:72–75.
   PubMedGoogle Scholar
• Newman-Toker J. 2000. Risperidone in anorexia nervosa. J Am Acad Child Adolesc Psychiatry 39:941–942.
   PubMed Web of Science ®Google Scholar
• NICE Guidelines (2004) Eating Disorders. Core interventions in treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. http://www.nice.org.uk/Guidance/CG9/Guidance/pdf/English
   Google Scholar
• Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, . 2005. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord 38:295–300.
   PubMed Web of Science ®Google Scholar
• Norgren S, Danielsson P, Jurold R, Lötborn M, Marcus C. 2003. Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatr. 92:666–70.
   PubMed Web of Science ®Google Scholar
• Norris ML, Spettigue W, Buchholz A, Henderson KA, Obeid N. 2010. Factors influencing research drug trials in adolescents with anorexia nervosa. Eat Disord. 18(3):210–7.
   Google Scholar
• O'Reardon JP, Allison KC, Martino NS, Lundgren JD, Heo M, Stunkard J. 2006. A Randomized, Placebo-Controlled Trial of Sertraline in the Treatment of Night Eating Syndrome. Am J Psychiatry 163:893–898.
   PubMed Web of Science ®Google Scholar
• Pearlstein T, Spurell E, Hohlstein LA, Gurney V, Read J, Fuchs C, . 2003. A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response. Arch Womens Ment Health 6:147–151.
   PubMedGoogle Scholar
• Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. 1983. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 140:554–558.
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI. 1989. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 9:254–259.
   PubMed Web of Science ®Google Scholar
• Powers PS, Santana CA, Bannon YS. 2002. Olanzapine in the treatment of Anorexia nervosa : an open label trial. Int J Eat Disord 32:146–154.
   PubMed Web of Science ®Google Scholar
• Powers PS, Bannon Y, Eubanks R, McCormick R. 2007. Quetiapine in Anorexia Nervosa Patients: An Open Label Outpatient Pilot Study. Int J Eat Disord 40:21–26.
   PubMed Web of Science ®Google Scholar
• Preti A, Usai A, Miotto P, Petretto DR, Masala C. 2008. Eating disorders among professional fashion models. Psychiatry Res 159(1-2):86–94
   Google Scholar
• Preti A, Girolamo G, Vilagut G, Alonso J, Graaf R, Bruffaerts R, Demyttenaere K, Pinto-Meza A, Haro JM, Morosini P; ESEMeD-WMH Investigators. 2009. The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res. 43(14):1125–32.
   Google Scholar
• Ricca V, Mannucci E, Mezzani B, Moretti S, Di Bernardo M, Bertelli M, . 2001. fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: A one-year follow-up study. Psychother Psychosom 70:298–298.
   PubMed Web of Science ®Google Scholar
• Ricca V, Castellini G, Lo Sauro C, Rotella CM, Faravelli C. 2009. Zonisamide Combined with Cognitive Behavioral Therapy in Binge Eating Disorder: A One-year Follow-up Study. Psychiatry (Edgmont). 6:23–8.
   PubMedGoogle Scholar
• Rigaud D, Brondel L, Poupard AT, Talonneau I, Brun JM. 2007. A randomized trial on the efficacy of a 2-month tube feeding regimen in anorexia nervosa: A 1-year follow-up study. Clin Nutr264:421–429.
   Google Scholar
• Romano SJ, Halmi KA, Sarkar NP, Koke SC, Lee JS. 2002. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 159:96–102.
   PubMed Web of Science ®Google Scholar
• Rothschild R, Quitkin HM, Quitkin FM, Steward JW, Ocepek-Welikson K, McGrath PJ, . 1994. Tricamo E. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives. International J Eat Dis 15:1–9.
   PubMed Web of Science ®Google Scholar
• Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Anorexia Nervosa. 2004. Australian and New Zealand clinical practice guidelines for the treatment of anorexia nervosa. Australian and New Zealand Journal of Psychiatry 38:659–670.
   PubMed Web of Science ®Google Scholar
• Ruggiero GM, Laini V, Mauri MC, Ferrari VM, Clemente A, Lugo F, Mantero M, Redaelli G, Zappulli D, Cavagnini F. 2001. A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics. Prog Neuropsychopharmacol Biol Psychiatry 25:1049–59.
   PubMed Web of Science ®Google Scholar
• Russell DM, Freedman ML, Feiglin DH, Jeejeebhoy KN, Swinson RP, Garfinkel PE. 1983. Delayed gastric emptying and improvement with domperidone in a patient with anorexia nervosa. Am J Psychiatry 140:1235–1236.
   PubMed Web of Science ®Google Scholar
• Sabine EJ, Yonace A, Farrington AJ, Barratt KH, Wakeling A. 1983 Bulimia nervosa : a placebo controlled double-blind therapeutic trial of mianserin. Br JClin Pharmac 15, 195–202.
   Google Scholar
• Safai-Kutti S. 1990. Oral zinc supplementation in anorexia nervosa. Acta Psychiatr Scand 361:14–17.
   Google Scholar
• Safer DL, Darcy AM, Lock J. 2011. Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: A case report. Int J Eat Disord 44:178–81.
   PubMed Web of Science ®Google Scholar
• Santonastaso P, Friederici S, Favaro A. 2001. Sertraline in the treatment of restricting anorexia nervosa: an open controlled trial. J Child Adolesc Psychopharmacol 11:143–150.
   PubMed Web of Science ®Google Scholar
• Saleh JW, Lebwohl P. 1979. Gastric emptying studies in patients with anorexia nervosa: the effects of metoclopramide. Gastroenterology 76:1233.
   Google Scholar
• Schmidt U, Cooper P, Essers H, Freeman CH, Holland RL, Palmer R, . 2004. Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled, multicenter study of short-term und long-term pharmacotherapy combinde with a stepped care approach to psychotherapy. J Clinical Psychopharmacol 24:549–552.
   PubMed Web of Science ®Google Scholar
• Sharif ZA, 2003. Pharmacokinetics, metabolism and drug-drug interactions of atypical antipsychotics in special populations. Prim Care Companion J Clin Psychiatry 5 (suppl5):22–25.
   Google Scholar
• Shay NF, Mangian HF. 2000. Neurobiology of zinc-influenced eating behavior J Nutr 130:1493–1493.
   PubMed Web of Science ®Google Scholar
• Signorini A, De Filippo E, Panico S, De Caprio C, Pasanisi F, Contaldo F. 2007. Long-term mortality in anorexia nervosa: a report after an 8-year follow-up and a review of the most recent literature. Eur J Clin Nutr 611:119–122.
   Google Scholar
• Silbert MV. 1971. The weight gain effect of periactin in anorexic patients. SAfr Med J45:374–377.
   Google Scholar
• Silveira RO, Zanatto V, Appolinário JC, Kapczinski F. 2005. An open trial of reboxetine in obese patients with binge eating disorder. Eat Weight Disord 10:e93–96.
   PubMedGoogle Scholar
• Sokol MS, Gray NS, Goldstein A, Kaye WH. 1999. Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder. Int J Eat Disord 25:233–237.
   PubMed Web of Science ®Google Scholar
• Spettigue W, Buchholz A, Henderson K, Feder S, Moher D, Kourad K, . 2008. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial. BMC Pediatrics 8:4.
   PubMed Web of Science ®Google Scholar
• Stacher G, Bergmann H, Wiesnagrotzki S, Kiss A, Schneider C, Mittelbach G, . 1987. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa. Gastroenterology 92:1000–1006.
   PubMed Web of Science ®Google Scholar
• Stacher G, Abatzi-Wenzel TA, Wiesnagrotzki S, Bergmann H, Schneider C, Gaupmann G. 1993. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. Br J Psychiatry 162:398–402.
   PubMed Web of Science ®Google Scholar
• Stefano SC, Bacaltchuk J, Blay SL, Appolinário JC. 2008. Antidepressants in short-term treatment of binge eating disorder: systematic review and meta-analysis. Eat Behav 9:129–129.
   PubMedGoogle Scholar
• Steinglass J, Sysko R, Schebendach J, Broft A, Strober M, Walsh BT. The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: a preliminary trial. J Psychiatr Pract. 2007;13:238–45.
   PubMedGoogle Scholar
• Stunkard A, Berkowitz R, Tanrikut C, Reiss E, Young L. 1996. d-fenfluramine treatment of binge eating disorder. Am J Psychiatry 153:1455–1459.
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Bulik CM, Fear JL, Pickering A. 1998. Outcome of anorexia nervosa: a case-control study. Am J Psychiatry 155(7):939–46.
   Google Scholar
• Sunblad CH, Landen M, Eriksson T, Bergman L, Eriksson E. 2005. Effects of the androgen inhibitor flutamide and the serotonin inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study. J Clin Psychopharmacology 25:85–85.
   Google Scholar
• Szmukler GI, Young GP, Miller G, Lichtenstein M, Binns DS. 1995. A controlled trial of cisapride in anorexia nervosa. Int J Eat Disord 17:347–57.
   PubMed Web of Science ®Google Scholar
• Trunko ME, Schwartz TA, Duvvuri V, Kaye WH. 2010. Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: Case reports. Int J Eat Disord.
   Google Scholar
• Vandereycken W. 1984. Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. Br J Psychiatry 144:288–292.
   PubMed Web of Science ®Google Scholar
• Vandereycken W, Pierloot R. 1982. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 66:445–445.
   PubMed Web of Science ®Google Scholar
• Vieweg WVR, Wood MA Tricyclic antidepressants, QT interval prolongation and torsade de points. Psychosomatics 45:371–371.
   Google Scholar
• Walsh BT, Stewart JW, Roose SP, Gladis M, Glassman AH. 1984. Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study. Arch Gen Psychiatry 41:1105–1109.
   PubMed Web of Science ®Google Scholar
• Walsh BT, Gladis M, Roose SP, Steward JW, Stetner F, Glassman AH. 1988. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 45:471–475.
   PubMed Web of Science ®Google Scholar
• Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. 1991. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 148:1206–1212.
   PubMed Web of Science ®Google Scholar
• Walsh BT, Agras WS, Devlin MJ, Fairburn CG, Wilson GT, Kahn C, . 2000. Fluoxetine for Bulimia Nervosa Following Poor Response to Psychotherapy. Am J Psychiatry 157:1332–1334.
   PubMed Web of Science ®Google Scholar
• Walsh BT, Kaplan AS, Attia E, Olmsted M, Parides M, Carter JC, . 2006a. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA 295:2605–2612.
   PubMed Web of Science ®Google Scholar
• Walsh BT, Sysko R, Parides MK. 2006b. Early response to desipramine among women with bulimia nervosa. Int J Eat Disord 39:72–75.
   PubMed Web of Science ®Google Scholar
• WHO (1991). World Health Organisation. Tenth Revision of the International Classification of Diseases, Chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic Guidelines. World Health Organisation, Geneva.
   Google Scholar
• Wilfley DE, Crow SJ, Hudson JI, Mitchell JE, Berkowitz RI, Blakesley V, . 2008. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry 165:51–58.
   PubMed Web of Science ®Google Scholar
• Yancy WS Jr, Westman EC, McDuffie JR, Grambow SC, Jeffreys AS, Bolton J, Chalecki A, Oddone EZ. 2010. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss. Arch Intern Med. 170:136–45.
   PubMedGoogle Scholar